Effect of tapering methotrexate in rheumatoid arthritis patients after add-on iguratimod therapy.
Not Applicable
Recruiting
- Conditions
- rheumatoid arthritis/remission
- Registration Number
- JPRN-UMIN000027719
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
add-on another csDMARDs or bDMARDs within 8 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method